Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: A report from the Children's Oncology Group-Reference-Cited by-同舟云学术

Higher dose imatinib for children with de novo chronic phase chronic myelogenous leukemia: A report from the Children's Oncology Group

Published:2011-04-04 Issue:1 Volume:57 Page:56-62
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Champagne Martin A.,Fu Cecilia H.,Chang Myron,Chen Helen,Gerbing Robert B.,Alonzo Todd A.,Cooley Linda D.,Heerema Nyla A.,Oehler Vivian,Wood Charlotte,French Mary Ellen,Arceci Robert J.,Smith Franklin O.,Bernstein Mark L.

Funder

Chair's Grant

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.23031/fullpdf

Reference35 articles.

1. Smith MA Gloeckler Ries LA Gurney JG 1999 17 34

2. Stem cell transplantation for chronic myeloid leukemia in children;Cwynarski;Blood,2003

3. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors;Davies;Am J Med,2001

4. Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: Experience of eight European Countries. The EBMT Paediatric Diseases Working Party;Dini;Bone Marrow Transplant,1996

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Room To Grow: Bosutinib Approved for Newly Diagnosed or Relapsed/Intolerant Pediatric Chronic Myeloid Leukemia;The Hematologist;2024

2. Myeloproliferative Disorders in Non-Down Syndrome Patients;Pediatric Oncology;2024

3. The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review;International Journal of Clinical Pharmacy;2023-12-26

4. Tyrosine Kinase Inhibitors in pediatric chronic myeloid leukemia: a focused review of clinical trials;Frontiers in Oncology;2023-12-20

5. Treatment and follow‐up of children with chronic myeloid leukaemia in chronic phase (CML‐CP) in the tyrosine kinase inhibitor (TKI) era—Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohort;British Journal of Haematology;2023-12-14